Open Government Portal
Total Insolvencies, Insolvencies Filed by Consumers, Insolvencies Filed by Businesses, Insolvencies Filed by Consumers by Province, Insolvencies Filed by Businesses by Province [Office of the Superintendent of Bankruptcy Canada]
Historical monthly insolvencies by receiverships
Total Insolvencies,
Insolvencies Filed by Consumers,
Insolvencies Filed by Businesses,
Insolvencies by NAICS Economic Sectors, Canada,
Insolvencies Filed by Consumers by ER,
Insolvencies Filed by Businesses by ER,
Insolvencies Filed by Consumers by Census Metropolitan Area (CMA),
Insolvencies Filed by Businesses by Census Metropolitan Area (CMA).
[Office of the Superintendent of Bankruptcy Canada]
This market research with Vietnamese consumers collected baseline consumer perceptions and stated behaviours of Canadian products and processes, and evolving market demands to help inform the upcoming strategic approach for the Canada Brand marketing campaign. Specific objectives of the research include, but are not limited to, providing AAFC with data on: Vietnamese food purchasing behaviours, Vietnamese media consumption habits, Canadian agriculture, food and seafood product awareness, Canadian food and seafood product purchase frequency, and demand for Canadian food and seafood products. The findings of the research are used in the development of policies, programs and initiatives, to improve communications and …
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to the Prescription Drug List (PDL) for human and veterinary use.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.